Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
EPA DSSTox provides the canonical identifier, structure, and synonym profile for this chemical.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Prevalence of DEXTROSE MONOHYDRATE in our catalog (fda_ndc).
Products
217
Catalog
Co-occurrence
Ingredients that frequently appear alongside DEXTROSE MONOHYDRATE in the catalog.
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 20000 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 938 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 30144 mg
Fruits des bois
HYDRATIS
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 188 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 30144 mg
US
FDA
Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 20 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 345 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 15009 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 11 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 92 mg
US
FDA
Route: ORAL; Dosage form: TROCHE; Maximum daily exposure: 4440 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 938 mg
US
FDA
FDA NDC lists this ingredient in 199 active drug products and 217 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.